ROIVANT SCIENCES LTD. (ROIV)

Import this data to Google Sheets with:

=jivedata("ROIV","financials")

Full statements spill as a table. For one cell: =jivedata("ROIV","Revenue") or =jivedata("ROIV","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

ROIVANT SCIENCES LTD.

ROIV • CIK 0001635088

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenue from Contract with Customer, Excluding Assessed Tax	$61,280	$29,053	$8,260	$7,532
	—	—	$770,235	$770,627
Operating Income (Loss)	$-1,175,318	$-1,003,294	$-515,068	$-596,139
Gain (Loss) on Investments	$-20,815	$55,186	$105,046	$160,808
Deconsolidation, Gain (Loss), Amount	$29,276	$3,108	$11,027	$11,027
Investment Income, Interest	—	—	$178,109	$166,709
Other Nonoperating Income (Expense)	$15,808	$-10,721	$4,012	$13,090
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$-1,224,834	$-681,590	$-264,578	$-289,880
Income Tax Expense (Benefit)	$5,190	$48,174	$133,329	$124,722
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest	$-1,230,024	$-729,764	$-397,907	$-414,596
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest	$114,561	$373,030	$0	$0
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$-1,115,463	$-356,734	$-397,907	$-414,602
Net Income (Loss) Attributable to Noncontrolling Interest	$-106,433	$-184,753	$-98,136	$-148,349
Net Income (Loss) Attributable to Parent	$-1,009,030	$-171,981	$-299,771	$-266,253
Research and Development Expense	$525,215	$550,413	$681,812	$730,909
General and Administrative Expense	—	$591,410	$610,466	$641,974
Operating Expenses	$1,236,598	$1,142,734	$1,293,563	$1,374,298
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent	$-1,123,591	$-545,166	$-299,771	$-299,771
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent	$114,561	$373,185	$0	$0
Weighted Average Number of Shares Outstanding, Basic	712,791,115	725,395,624	693,864,530	734,354,347
Share-based Payment Arrangement, Noncash Expense	$217,781	$289,029	$346,165	$347,329

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$1,676,813	$2,715,411	$1,419,232	$1,248,456
Marketable Securities, Current	—	$2,171,480	$2,872,601	$2,593,626
Property, Plant and Equipment, Net	$39,086	$12,056	$11,986	$11,320
Operating Lease, Right-of-Use Asset	$53,251	$89,021	$80,416	$78,886
Other Assets, Current	$121,774	$113,173	$105,316	$128,371
Investments, Fair Value Disclosure	$304,317	$302,939	$407,985	$444,622
Assets, Current	$1,798,587	$5,000,064	$5,167,384	$4,742,080
Other Assets, Noncurrent	$49,482	$32,860	$40,916	$29,585
Assets	$2,389,604	$5,436,940	$5,708,687	$5,306,493
Operating Lease, Liability, Noncurrent	$53,476	$90,328	$96,291	$94,768
Other Liabilities, Noncurrent	$17,032	$22	$70	$6,253
Liabilities	$782,017	$249,742	$416,275	$384,624
Accounts Payable, Current	$37,830	$23,691	$18,002	$25,084
Accrued Liabilities, Current	$167,129	$114,294	$205,823	$168,740
Operating Lease, Liability, Current	$11,693	$9,842	$11,147	$12,384
Taxes Payable, Current	$542	$416	$45,689	$74,182
Other Liabilities, Current	$15,076	$1,584	$583	$3,213
Liabilities, Current	$272,448	$149,411	$281,244	$283,603
Common Stock, Value, Issued	$0	$0	$0	$0
Additional Paid in Capital	$4,933,137	$4,562,107	$5,024,826	$5,130,926
Retained Earnings (Accumulated Deficit)	$-3,772,754	$116,060	$-501,814	$-900,354
Accumulated Other Comprehensive Income (Loss), Net of Tax	$-2,617	$9,438	$4,358	$701
Stockholders' Equity Attributable to Parent	$1,157,766	$4,687,605	$4,527,370	$4,231,273
Stockholders' Equity Attributable to Noncontrolling Interest	$449,821	$499,593	$765,042	$690,596
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	$1,607,587	$5,187,198	$5,292,412	$4,921,869
Common Stock, Shares Authorized	7,000,000,000	7,000,000,000	7,000,000,000	7,000,000,000
Common Stock, Shares, Issued	760,143,393	695,938,323	720,352,386	722,668,062
Employee-related Liabilities, Current	$55,186	$53,928	$87,325	$40,820
Other Accrued Liabilities, Current	$18,096	$14,553	$25,749	$14,482
Research and Development Expense	$525,215	$550,413	$681,812	$202,016

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations	—	$747	$3,767	$3,267
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-381,919	$-3,824,789	$-1,294,679	$11,934
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations	—	$2,725,661	$1,430,982	$1,442,916
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$-1,115,463	$-356,734	$-397,907	$-414,602
Net Cash Provided by (Used in) Operating Activities	$-843,393	$-839,451	$-750,349	$-816,470
Proceeds from Divestiture of Interest in Consolidated Subsidiaries	—	$260,586	$0	$0
Cash Divested from Deconsolidation	$6,706	$31,223	$4,418	$4,418
Payments to Acquire Property, Plant, and Equipment	$12,690	$4,599	$8,209	$4,593
Payments for (Proceeds from) Other Investing Activities	$-702	$-79	$2,518	$2,518
Net Cash Provided by (Used in) Investing Activities	$-44,269	$-1,766,291	$-682,333	$684,643
Payments for Repurchase of Common Stock	—	$1,293,232	—	—
Proceeds from Issuance of Common Stock	$311,981	$0	$0	$0
Proceeds from Stock Options Exercised	$2,814	$49,597	$268,350	$314,312
Proceeds from Stock Plans	$316	$1,028	$1,155	$1,790
Finance Lease, Principal Payments	$692	$774	$0	$0
Proceeds from Warrant Exercises	—	$0	$0	$0
Net Cash Provided by (Used in) Financing Activities	$499,462	$-1,219,794	$134,236	$140,494
Interest Paid, Excluding Capitalized Interest, Operating Activities	$5,303	$5,963	$0	$0
Share-based Payment Arrangement, Noncash Expense	$217,781	$289,029	$346,165	$347,329
Gain (Loss) on Investments	$-20,815	$55,186	$105,046	$160,808
Deconsolidation, Gain (Loss), Amount	$29,276	$3,108	$11,027	$11,027
Operating Lease, Impairment Loss	—	—	$15,594	$15,594
Gain (Loss) on Extinguishment of Debt	—	$-8,848	$0	$0
Depreciation, Depletion and Amortization	$18,857	$14,071	$3,348	$2,850
Operating Lease, Right-of-Use Asset, Amortization Expense	$7,565	$6,843	$8,276	$7,727
Other Noncash Income (Expense)	$21,206	$-3,762	$-1,828	$-535
Increase (Decrease) in Other Current Assets	$31,670	$25,070	$-11,459	$12,505
Increase (Decrease) in Other Noncurrent Assets	—	$8,758	$7,416	$2,608
Increase (Decrease) in Accounts Payable, Trade	$4,359	$-18,168	$3,418	$22,272
Increase (Decrease) in Accrued Liabilities	$38,956	$-10,070	$59,326	$70,415
IncreaseDecreaseInOperatingLeaseLiability	$-8,604	$-5,700	$-2,385	$-2,193
Increase (Decrease) in Income Taxes Payable	—	—	$85,045	$77,864
Increase (Decrease) in Other Operating Liabilities	—	$-9,280	$-1,008	$1,057
Payments to Acquire Debt Securities, Available-for-sale	—	—	$4,795,855	$3,280,684
Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale	—	—	$1,122,300	$1,690,489
Payments to Acquire Held-to-maturity Securities	—	—	$0	$0
Proceeds from Maturities, Prepayments and Calls of Held-to-maturity Securities	—	—	$2,185,000	$1,465,000

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("ROIV","financials")

Full statements spill as a table. For one cell: =jivedata("ROIV","Revenue") or =jivedata("ROIV","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.